We’re happy to share that our National Center for Prenatal and Postnatal Resources has been invited to Washington DC on March 8 to help lead patient advocacy conversations on prenatal genetics at an American Congress of Obstetricians and Gynecologists (ACOG) as part of their Advisory Panels on Precision Medicine and Prenatal Genetics (cfDNA).
We will be presenting the following sessions at the Down syndrome leadership conference in St. Louis, MO Feb. 28-Mar. 3, 2019: Brace for the Changing Landscape of Prenatal Testing: What Every Affiliate Should Know 2:00 PM – 3:15 PM, Fri, Mar 1, 2019 by Mark Leach and Stephanie Meredith Over the past year, prenatal testing labs have strongly lobbied ACOG Read more…
October 29-30, we will be speaking about the impact of non-invasive prenatal screening on patient advocacy groups and the challenges of navigating ethically ambiguous territory, as well as some possible solutions for creating an education infrastructure as prenatal screening expands.
Proposal Title: A Default Panel for Expanded Prenatal Testing: Could Embracing Routinization Be Consistent with Respecting Autonomy and Justice? American Society for Bioethics & Humanities Anaheim, California October 19, 2018